4.6 Article

Carbon-Ion Radiotherapy Combined with Concurrent Chemotherapy for Locally Advanced Pancreatic Cancer: A Retrospective Case Series Analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Gastroenterology & Hepatology

Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a systematic review and meta-analysis

Boqiang Zhao et al.

Summary: Carbohydrate antigen 19-9 (CA19-9) is a widely used serum biomarker for detecting pancreatic cancer. This study comprehensively evaluated the diagnostic efficacy of CA19-9 and found that it has high sensitivity, specificity, and accuracy in diagnosing pancreatic cancer, making it valuable for early detection and warning.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Oncology

Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)

I Hartlapp et al.

Summary: CA 19-9 response has prognostic and predictive value in patients with locally advanced pancreatic cancer, and can be used to select patients for exploratory surgery.

ESMO OPEN (2022)

Article Oncology

The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer

Silvia Molinelli et al.

Summary: This study aimed to quantify the benefits of robust optimization in neoadjuvant carbon ion therapy for pancreatic cancer. The results showed that online adaptation improved treatment quality and some patients required re-optimization to meet treatment goals.

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Feasibility and Safety of Repeated Carbon Ion Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer

Masahiko Okamoto et al.

Summary: The study evaluated the feasibility and safety of re-irradiation with carbon ion beams for locally recurrent unresectable pancreatic cancer (URPC) after carbon ion radiotherapy (CIRT). The results showed that repeated CIRT is feasible with acceptable toxicity for selected patients with locally advanced URPC after CIRT.

CANCERS (2021)

Article Medicine, General & Internal

A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer

Masaru Fukahori et al.

Summary: Gemcitabine plus nab-paclitaxel (GnP) treatment in patients with locally advanced pancreatic cancer showed favorable tumor shrinkage, good toxicity profile, and enabled conversion to surgical resection in a subset of patients; therefore, GnP is an option for first-line chemotherapy in patients with LAPC.

MEDICINE (2021)

Article Oncology

Predicting overall survival and resection in patients with locally advanced pancreatic cancer treated with FOLFIRINOX: Development and internal validation of two nomograms

Lilly J. H. Brada et al.

Summary: This study analyzed data from 252 patients with locally advanced pancreatic cancer, identifying independent factors predicting overall survival and resection, and developed two prognostic nomograms.

JOURNAL OF SURGICAL ONCOLOGY (2021)

Article Oncology

Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy

Yasuhito Hagiwara et al.

Summary: This study investigated the feasibility and efficacy of carbon-ion re-irradiation for patients with pancreatic cancer who experienced recurrence after initial C-ion RT. The results showed that repeating C-ion RT may be a reasonable option with tolerable toxicity for patients with recurrent pancreatic cancers, and adjuvant chemotherapy appears to improve the local control rate.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2021)

Article Oncology

Carbon Ion Radiation Therapy With Concurrent Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

Makoto Shinoto et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

Article Medicine, General & Internal

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Gastroenterology & Hepatology

Combined radiochemotherapy in patients with locally advanced pancreatic cancer: A meta-analysis

Yue Chen et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Article Medicine, General & Internal

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)